Societal CDMO Inc
F:RAH

Watchlist Manager
Societal CDMO Inc Logo
Societal CDMO Inc
F:RAH
Watchlist
Price: 1.58 EUR Market Closed
Market Cap: 165.5m EUR
Have any thoughts about
Societal CDMO Inc?
Write Note

Intrinsic Value

The intrinsic value of one RAH stock under the Base Case scenario is 1.35 EUR. Compared to the current market price of 1.58 EUR, Societal CDMO Inc is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RAH Intrinsic Value
1.35 EUR
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Societal CDMO Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for RAH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about RAH?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Societal CDMO Inc

Provide an overview of the primary business activities
of Societal CDMO Inc.

What unique competitive advantages
does Societal CDMO Inc hold over its rivals?

What risks and challenges
does Societal CDMO Inc face in the near future?

Summarize the latest earnings call
of Societal CDMO Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Societal CDMO Inc.

Provide P/S
for Societal CDMO Inc.

Provide P/E
for Societal CDMO Inc.

Provide P/OCF
for Societal CDMO Inc.

Provide P/FCFE
for Societal CDMO Inc.

Provide P/B
for Societal CDMO Inc.

Provide EV/S
for Societal CDMO Inc.

Provide EV/GP
for Societal CDMO Inc.

Provide EV/EBITDA
for Societal CDMO Inc.

Provide EV/EBIT
for Societal CDMO Inc.

Provide EV/OCF
for Societal CDMO Inc.

Provide EV/FCFF
for Societal CDMO Inc.

Provide EV/IC
for Societal CDMO Inc.

What are the Revenue projections
for Societal CDMO Inc?

How accurate were the past Revenue estimates
for Societal CDMO Inc?

What are the Net Income projections
for Societal CDMO Inc?

How accurate were the past Net Income estimates
for Societal CDMO Inc?

What are the EPS projections
for Societal CDMO Inc?

How accurate were the past EPS estimates
for Societal CDMO Inc?

What are the EBIT projections
for Societal CDMO Inc?

How accurate were the past EBIT estimates
for Societal CDMO Inc?

Compare the revenue forecasts
for Societal CDMO Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Societal CDMO Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Societal CDMO Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Societal CDMO Inc compared to its peers.

Compare the P/E ratios
of Societal CDMO Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Societal CDMO Inc with its peers.

Analyze the financial leverage
of Societal CDMO Inc compared to its main competitors.

Show all profitability ratios
for Societal CDMO Inc.

Provide ROE
for Societal CDMO Inc.

Provide ROA
for Societal CDMO Inc.

Provide ROIC
for Societal CDMO Inc.

Provide ROCE
for Societal CDMO Inc.

Provide Gross Margin
for Societal CDMO Inc.

Provide Operating Margin
for Societal CDMO Inc.

Provide Net Margin
for Societal CDMO Inc.

Provide FCF Margin
for Societal CDMO Inc.

Show all solvency ratios
for Societal CDMO Inc.

Provide D/E Ratio
for Societal CDMO Inc.

Provide D/A Ratio
for Societal CDMO Inc.

Provide Interest Coverage Ratio
for Societal CDMO Inc.

Provide Altman Z-Score Ratio
for Societal CDMO Inc.

Provide Quick Ratio
for Societal CDMO Inc.

Provide Current Ratio
for Societal CDMO Inc.

Provide Cash Ratio
for Societal CDMO Inc.

What is the historical Revenue growth
over the last 5 years for Societal CDMO Inc?

What is the historical Net Income growth
over the last 5 years for Societal CDMO Inc?

What is the current Free Cash Flow
of Societal CDMO Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Societal CDMO Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Societal CDMO Inc

Current Assets 53.5m
Cash & Short-Term Investments 8.1m
Receivables 29.4m
Other Current Assets 16m
Non-Current Assets 100m
PP&E 54.8m
Intangibles 43.3m
Other Non-Current Assets 1.9m
Current Liabilities 50m
Accounts Payable 1.3m
Accrued Liabilities 11.4m
Other Current Liabilities 37.3m
Non-Current Liabilities 44.8m
Long-Term Debt 339k
Other Non-Current Liabilities 44.5m
Efficiency

Earnings Waterfall
Societal CDMO Inc

Revenue
94.6m USD
Cost of Revenue
-76.5m USD
Gross Profit
18.1m USD
Operating Expenses
-21.7m USD
Operating Income
-3.6m USD
Other Expenses
-9.7m USD
Net Income
-13.3m USD

Free Cash Flow Analysis
Societal CDMO Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Societal CDMO reported a revenue jump to $23.6 million for Q3 2023, up from $21.6 million the previous year, citing increased demand for Verapamil products. Despite the rise, a net loss widened to $4.6 million ($0.05 per diluted share) from $3.3 million ($0.06 per diluted share), and adjusted EBITDA fell to $2.8 million from $3.8 million. For the nine months, revenue inched up to $66.9 million from $65.9 million, while net loss also grew to $12.5 million. The company is streamlining operations, expecting to reduce annualized costs by $5.5 million and revising 2023 revenue guidance to $92-$94 million, with adjusted EBITDA projected at $11.5-$13 million.

What is Earnings Call?
Fundamental Scores

RAH Profitability Score
Profitability Due Diligence

Societal CDMO Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
33/100
Profitability
Score

Societal CDMO Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

RAH Solvency Score
Solvency Due Diligence

Societal CDMO Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
44/100
Solvency
Score

Societal CDMO Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RAH Price Targets Summary
Societal CDMO Inc

There are no price targets for RAH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for RAH?

Click here to dive deeper.

Dividends

Societal CDMO Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RAH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Societal CDMO Inc Logo
Societal CDMO Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

165.7m EUR

Dividend Yield

0%

Description

Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The company is headquartered in Exton, Pennsylvania and currently employs 258 full-time employees. The company went IPO on 2014-03-07. Societal CDMO is principally focused on solving various manufacturing problems. The company is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. In addition to its experience in handling Drug Enforcement Agency (DEA) controlled substances and developing and manufacturing modified-release dosage forms, the Company has the ability to deliver on its clients pharmaceutical development and manufacturing projects. The company conducts its operations in Gainesville, Georgia and San Diego, California.

Contact

PENNSYLVANIA
Exton
1 E. Uwchlan Ave, Suite 112
+17705348239.0
ir.recropharma.com

IPO

2014-03-07

Employees

258

Officers

See Also

Discover More
What is the Intrinsic Value of one RAH stock?

The intrinsic value of one RAH stock under the Base Case scenario is 1.35 EUR.

Is RAH stock undervalued or overvalued?

Compared to the current market price of 1.58 EUR, Societal CDMO Inc is Overvalued by 15%.

Back to Top